TGM2-deficient mice exhibit impaired T cell activation and a reduced the proportion of MDSC/tumor-associated macrophage (TAM) cells, significantly enhancing anti-tumor immunity within the TME (24). The gene discussed is TGM2; the disease is neoplasm.